医学高质量论文简报（周报） · 行业新闻

The FDA has approved AI/ML-enabled medical devices across many medical subspecialties (Figure 3a). An important insight from these data is that the majority, 531 (about 77%), of FDA-approved AI/ML-ena

June 17, 2026 # AI Medical Devices: FDA Approval Process Concise guide to FDA pathways, required evidence, and postmarket controls for AI/ML medical devices (510(k), De Novo, PMA, PCCP). If your AI

The FDA has been approving AI-based devices for years but didn’t initially distinguish them as a unique category. A few years back, we at The Medical Futurist Institute took it upon ourselves to sift

Despite the increasing number of AI-enabled medical devices the FDA has yet to establish a unique regulatory pathway for these devices. Most approvals follow a 510(k) pathway according to their risk l

Dec 05, 2024 - 01:45 PM FDA Update 900x400 The Food and Drug Administration yesterday released recommendations for streamlining the approval process for medical devices that use artificial intellige

Artificial intelligence has emerged as a transformative healthcare technology, reshaping diagnosis, disease monitoring and treatment across multiple clinical applications, including the rapidly evolvi

# Artificial intelligence (AI) and the healthcare industry Artificial intelligence (AI) is transforming the healthcare industry, revolutionizing the way care is delivered, research is conducted, and

How Has AI Impacted the Health Industry? AI for healthcare offers the ability to process and analyze vast amounts of medical data far beyond human capacity. The benefits of AI in healthcare include f

At Google DeepMind, our journey in medical AI has evolved from mastering examination-style tests of medical knowledge with MedPaLM, to matching physician performance in text-based simulated medical co

Today in Nature Medicine, we’ve published our joint paper with Google Research, which proposes CoDoC (Complementarity-driven Deferral-to-Clinical Workflow), an AI system that learns when to rely on pr

Demos: https://x.com/googledeepmind/status/2049867061279457761?s=46&t=vmJVGJkpKsC9IiIufpKR0w “At Google DeepMind, our journey in medical AI has evolved

AlphaFold, an AI model from Google DeepMind, is revolutionizing our understanding of proteins, the building blocks of life. By rapidly predicting their complex 3D shapes, AlphaFold is supporting scien

# DeepMind’s health team joins Google Health Over the last three years, DeepMind has built a team to tackle some of healthcare’s most complex problems—developing AI research and mobile tools that are

## What is OpenAI to help Healthcare? OpenAI for Healthcare is an extensive set of AI-driven applications and workflows specifically designed for clinical use. The core of the system is ChatGPT, spec

OpenAI has announced OpenAI for Healthcare, a set of AI products intended for use by healthcare organizations in clinical, administrative, and research settings. The release includes ChatGPT for Healt

Last Thursday, OpenAI introduced OpenAI for Healthcare, a suite of secure AI products designed to help health care organizations deliver more high-quality care, reduce administrative burden, and power

Title: OpenAI Launches OpenAI for Healthcare **SAN FRANCISCO — January 2026** — OpenAI today announced **OpenAI for Healthcare**, a new initiative focused on helping healthcare organizations responsib

Industry observers say the growing adoption of AI in healthcare reflects rising demand for technologies capable of assisting doctors, reducing administrative burdens, and improving patient care effici

Artificial Intelligence (AI) has revolutionized the field of drug discovery, and a growing number of AI-discovered drugs are advancing into clinical trials, with an 80–90% success rate in phase 1 tria

Horizontal Logo 609.466.8991 Toll-Free: 800.257.5282 — the simulation of human intelligence in machines — has become an instrumental force in modern healthcare. It is rapidly transforming the la

This article has been updated A randomized phase 2a clinical trial of an AI-discovered drug and target combination for idiopathic pulmonary fibrosis shows safety and signs of efficacy, marking a conc

This gives physicians the potential to enhance their research programs in AI by cooperating actively with pharmaceutical companies and those involved with AI in various capacities. AI is aiding in dru

In early 2020, Exscientia announced the first-ever AI-designed drug molecule to enter human clinical trials. In July 2021, an AI system by DeepMind called AlphaFold predicted the protein structures f

# 2025 year-end digital health funding overview: A tale of two markets In a turbulent year for healthcare and the broader market, digital health started to feel less like a tremor of innovation and m

Awards + DEI Awards + Innovation Awards Resources + Webinars + Fierce Events + Industry Events + Podcasts + Survey + Whitepapers Events Subscribe Fierce Pharma Fierce Biotech Fi

Awards + DEI Awards + Innovation Awards Resources + Webinars + Fierce Events + Industry Events + Podcasts + Survey + Whitepapers Events Subscribe Fierce Pharma Fierce Biotech Fi

Recent digital health funding announcements indicate how much digital health startups have raised — investors are setting their sights on digital health players and early-stage startups with innovativ

## A quick summary table | Metric | Value | --- | | Most funded startup | Amwell, $1.7B raised | | Second most funded startup | Hinge Health, $1.1B raised | | Largest funding round | Amwell, $922M I